Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PCI Biotech Holding Director's Dealing 2019

Oct 18, 2019

3709_dirs_2019-10-18_9a9c64d0-5265-4170-8600-8d27aa326c45.html

Director's Dealing

Open in viewer

Opens in your device viewer

PCI Biotech: Mandatory notification regarding trade of shares

PCI Biotech: Mandatory notification regarding trade of shares

Stocken Invest AS, a wholly owned company by Lars Viksmoen, has on 18 October

2019 transferred 12,966 shares in PCI Biotech Holding ASA ("PCI Biotech") to

Lars Viksmoen, board member of PCI Biotech, at an average price of NOK 26.80 per

share.

After the transaction, Lars Viksmoen holds 12,966 shares in PCI Biotech and

Stocken Invest AS holds 0 shares in PCI Biotech.

This information is subject to the disclosure requirements pursuant to section

4-2 of the Norwegian Securities Trading Act.